And this30 Mar 2018 14:14
The Board believes the bioprocessing market to be a strong opportunity for Microsaic's MS detectors, with the potential to drive substantial new revenues from new customers with global reach. The total Biologics Market is estimated to be approximately $450Bn by 2019, which represents a third of total revenues in the Pharmaceutical sector. The rate of biologic production line installations represents a significant investment for this sector, with a current estimated value of approximately $20Bn either in planning or underway.